These pro-survival effects of Pax3 suggest that it can cooperate with other oncogenic drivers, either through inhibition of p53-dependent apoptosis or by promoting proliferation, functions that it provides to other types of cancer cells, including glioblastoma cell lines [33,55-57]. This evidence concerns the gene TP53 and glioblastoma.